TMED3 and clear cell renal carcinoma: Moreover, Ha et al. [9] recently proposed that TMED3 was highly expressed in patients with clear cell renal cell carcinoma who suffered from poor prognosis, indicating that it may be a potential prognostic factor in the therapy of clear cell renal cell carcinoma.